Results 161 to 170 of about 53,608 (389)

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

open access: yesMolecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou   +11 more
wiley   +1 more source

Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer

open access: yesMolecular Oncology, EarlyView.
This study employed targeted metabolomic profiling to identify 302 distinct metabolites present in platelet‐rich plasma (PRP), revealing aberrant metabolic profiles amongst individuals diagnosed with colorectal cancer (CRC). Compared to carcinoembryonic antigen (CEA) and cancer antigen 19‐9 (CA199), our metabolite panel showed improved sensitivity ...
Zuojian Hu   +7 more
wiley   +1 more source

Quantum Steganography

open access: yes, 2010
Steganography is the process of hiding secret information by embedding it in an "innocent" message. We present protocols for hiding quantum information in a codeword of a quantum error-correcting code passing through a channel. Using either a shared classical secret key or shared entanglement the sender (Alice) disguises her information as errors in ...
Shaw, Bilal A., Brun, Todd A.
openaire   +2 more sources

Inhibition of acyl‐CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction

open access: yesMolecular Oncology, EarlyView.
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy   +12 more
wiley   +1 more source

Convolutional Video Steganography with Temporal Residual Modeling [PDF]

open access: yesarXiv, 2018
Steganography represents the art of unobtrusively concealing a secrete message within some cover data. The key scope of this work is about visual steganography techniques that hide a full-sized color image / video within another. A majority of existing works are devoted to the image case, where both secret and cover data are images.
arxiv  

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

open access: yesMolecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia   +17 more
wiley   +1 more source

Applying statistical methods to text steganography [PDF]

open access: yesarXiv, 2011
This paper presents a survey of text steganography methods used for hid- ing secret information inside some covertext. Widely known hiding techniques (such as translation based steganography, text generating and syntactic embed- ding) and detection are considered. It is shown that statistical analysis has an important role in text steganalysis.
arxiv  

A Secure Image Steganography using LSB, DCT and Compression Techniques on Raw Images [PDF]

open access: green, 2005
K B Raja   +3 more
openalex   +1 more source

Integration of single‐cell and bulk RNA‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer

open access: yesMolecular Oncology, EarlyView.
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley   +1 more source

Home - About - Disclaimer - Privacy